Suppr超能文献

急诊创伤手术期间血管加压药的使用。

Vasopressor use during emergency trauma surgery.

作者信息

Van Haren Robert M, Thorson Chad M, Valle Evan J, Guarch Gerardo A, Jouria Jassin M, Busko Alexander M, Namias Nicholas, Livingstone Alan S, Proctor Kenneth G

机构信息

Dewitt-Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Ryder Trauma Center, Miami, Florida, USA.

出版信息

Am Surg. 2014 May;80(5):472-8.

Abstract

Most evidence suggests early vasopressor use is associated with death after trauma, but no previous study has focused on patients requiring emergency operative intervention (OR). We test the hypothesis that vasopressors are harmful in this population. Records from 746 patients requiring OR from July 2009 to March 2013 were retrospectively reviewed and stratified based on vasopressor use (epinephrine [EPI], phenylephrine, ephedrine, norepinephrine, dobutamine, vasopressin) or no vasopressor use. Vasopressors were administered to 225 patients (30%) during OR; 59 patients (8%) received multiple vasopressors. Patients who received vasopressors were older, more severely injured, had worse vital signs, and increased mortality rate (all P < 0.001). EPI was independently associated with mortality (odds ratio, 6.88; P = 0.001). If patients who received EPI were excluded, there was no difference in mortality between those who received vasopressors alone or in combination and those that did not (5 vs 6%, P = 0.523), although multiple markers of injury severity were worse. We conclude that vasopressor use is relatively common in the most severely injured patients requiring OR and is associated with mortality. EPI is most often used for cardiac arrest, whereas other vasopressors are used for their vasoconstrictive properties. This suggests that, except for EPI, vasopressors during OR are not independently associated with mortality.

摘要

大多数证据表明,创伤后早期使用血管升压药与死亡相关,但此前尚无研究聚焦于需要紧急手术干预(OR)的患者。我们检验了血管升压药对这一人群有害的假设。对2009年7月至2013年3月期间746例需要进行手术的患者的记录进行回顾性分析,并根据是否使用血管升压药(肾上腺素[EPI]、去氧肾上腺素、麻黄碱、去甲肾上腺素、多巴酚丁胺、血管加压素)进行分层。225例患者(30%)在手术期间使用了血管升压药;59例患者(8%)接受了多种血管升压药。使用血管升压药的患者年龄更大、受伤更严重、生命体征更差且死亡率更高(所有P<0.001)。EPI与死亡率独立相关(比值比,6.88;P = 0.001)。如果排除接受EPI的患者,单独或联合使用血管升压药的患者与未使用血管升压药的患者在死亡率上没有差异(5%对6%,P = 0.523),尽管多项损伤严重程度指标更差。我们得出结论,在需要进行手术的最严重受伤患者中,使用血管升压药相对常见且与死亡率相关。EPI最常用于心脏骤停,而其他血管升压药则因其血管收缩特性而使用。这表明,除EPI外,手术期间使用血管升压药与死亡率无独立关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验